<DOC>
	<DOCNO>NCT00321750</DOCNO>
	<brief_summary>Background hypothesis . Oral erosive lichen planus ( OELP ) severe form mucosal lichen planus . Lesions often induce intense pain limit feeding . Its course chronic flare spontaneous remission rare . Treatment difficult : topical steroid usually use first antimalarial , oral retinoids , systemic steroid , immunosuppressive drug even extracorporeal photochemotherapy necessary treating severe form . The need novel therapy less morbidity obvious . Calcineurin inhibitor theoretical interest treat OELP : emphasize several open study perform topical tacrolimus . The effectiveness 1 % pimecrolimus cream suggest case report one recent comparative study confirm potential interest topical pimecrolimus treat OELP . The absorption pimecrolimus human mucosa still unknown . Its application ulcerative lesion OELP one , could lead significant systemic level molecule . Objective : To evaluate efficacy 1 % pimecrolimus cream treat oral erosive lichen planus ( OELP ) ass tolerance .</brief_summary>
	<brief_title>Treatment Oral Erosive Lichen Planus With Pimecrolimus Cream</brief_title>
	<detailed_description>Background hypothesis . Oral erosive lichen planus ( OELP ) severe form mucosal lichen planus . Lesions often induce intense pain limit feeding . Its course chronic flare spontaneous remission rare . Treatment difficult : topical steroid usually use first antimalarial , oral retinoids , systemic steroid , immunosuppressive drug even extracorporeal photochemotherapy necessary treating severe form . The need novel therapy less morbidity obvious . Calcineurin inhibitor theoretical interest treat OELP : emphasize several open study perform topical tacrolimus . The effectiveness 1 % pimecrolimus cream suggest case report one recent comparative study confirm potential interest topical pimecrolimus treat OELP . The absorption pimecrolimus human mucosa still unknown . Its application ulcerative lesion OELP one , could lead significant systemic level molecule . Objective : To evaluate efficacy 1 % pimecrolimus cream treat oral erosive lichen planus ( OELP ) ass tolerance . Design : Double blind randomized trial placebo control . Settings : Outpatients Department Dermatology University hospital Nice , France . Patients : Fourteen consecutive patient OELP confirm histological examination clinical score superior 3 . 1 % pimecrolimus cream vehicle apply ulcerated lesion twice day 4 week . Main outcome measure ; efficacy treatment quantify use 12 point clinical score . Blood level pimecrolimus analyze D0 , D14 D28 .</detailed_description>
	<mesh_term>Lichen Planus</mesh_term>
	<mesh_term>Pimecrolimus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Confirmation diagnosis OELP histological examination clinical score superior 3 Patients 18 year Pregnancy breast feeding Malignancy Severe recurrent infection Uncontrolled chronic disorder Congenital acquire immunosuppression concomitant treatment potentially effective OELP antimalarial , oral retinoids , steroid immunosuppressive drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>Oral erosive lichen planus</keyword>
	<keyword>pimecrolimus cream</keyword>
</DOC>